MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hon.3030

Медицинская библиотека · Hematological oncology · 2022

Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.

Kumari Sarita, Ali M Shadab, Singh Jay, Arora Mohit, Verma Deepak, Pandey Avanish Kumar, Benjamin Mercilena, Bakhshi Sameer, Palanichamy Jayanth Kumar, Sharma Atul, Singh Inder, Tanwar Pranay, Singh Amar Ranjan, Pushpam Deepam, Qamar Imteyaz, Chopra Anita

СтатьяПеревод пока не подготовлен

Аннотация

T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease, characterized by an abnormal transformation of T cells into highly proliferative leukemic lymphoblasts. Identification of common genetic alterations has provided promising opportunities for better risk stratification in T-ALL. Current treatment in T-ALL still poses the major challenge of integrating the knowledge of molecular alterations in the clinical setting. We utilized the Multiplex Ligation Dependent Probe Amplification (MLPA) method to determine the frequency of common copy number alterations (CNAs) in 128 newly diagnosed T-ALL patients. We also studied the association of these CNAs with patient's clinical characteristics and survival. The highest frequency of deletion was observed in CDKN2A (59.38%), followed by CDKN2B (46.88%), LMO1 (37.5%), and MTAP (28.12%). PTPN2 (22.66%), PHF6 (14.06%), and MYB (14.06%) had the highest number of duplication events. A total of 89.06% patients exhibited CNAs. STIL::TAL1, NUP214::ABL1, and LMO2::RAG2 fusions were observed in 5.47%, 3.12%, and 0.78% of patients, respectively. CDKN2A, CDKN2B, and PTPN2 gene deletions were mainly observed in pediatric patients, while CNAs of NF1 and SUZ12 were observed more frequently in adults. In pediatric patients, alterations in CDKN2B, CASP8AP2, and AHI1 were associated with poor prognosis, while SUZ12 and NF1 CNAs were associated with favorable prognosis. In adult patients, ABL1 CNA emerged as an independent indicator of poor prognosis. The observed molecular heterogeneity in T-ALL may provide the basis for variations observed in clinical response in T-ALL and MLPA based CNA detection may help in risk stratification of these patients.

Для цитирования: Kumari Sarita, Ali M Shadab, Singh Jay, Arora Mohit, Verma Deepak, Pandey Avanish Kumar, Benjamin Mercilena, Bakhshi Sameer, Palanichamy Jayanth Kumar, Sharma Atul, Singh Inder, Tanwar Pranay, Singh Amar Ranjan, Pushpam Deepam, Qamar Imteyaz, Chopra Anita. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.. Hematological oncology. 2022. DOI: 10.1002/hon.3030.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.